Search Legislation

Commission Implementing Regulation (EU) 2019/2076Show full title

Commission Implementing Regulation (EU) 2019/2076 of 29 November 2019 granting a Union authorisation for the biocidal product family ‘Contec IPA Product Family’ (Text with EEA relevance)

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Changes over time for: Commission Implementing Regulation (EU) 2019/2076

 Help about opening options

Changes to legislation:

This version of this Regulation was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

Commission Implementing Regulation (EU) 2019/2076

of 29 November 2019

granting a Union authorisation for the biocidal product family ‘Contec IPA Product Family’

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products(1), and in particular the first subparagraph of Article 44(5) thereof,

Whereas:

(1) On 29 June 2016, Contec Europe, submitted an application in accordance with Article 43(1) of Regulation (EU) No 528/2012 for authorisation of a biocidal product family named ‘Contec IPA Product Family’ of product-types 2 and 4, as described in Annex V to that Regulation, providing written confirmation that the competent authority of United Kingdom had agreed to evaluate the application. The application was recorded under the case number BC-LA025582-58 in the Register for Biocidal Products.

(2) ‘Contec IPA Product Family’ contains propan-2-ol, as the active substance, which is included in the Union list of approved active substances referred to in Article 9(2) of Regulation (EU) No 528/2012.

(3) On 22 August 2018, the evaluating competent authority submitted, in accordance with Article 44(1) of Regulation (EU) No 528/2012, an assessment report and the conclusions of its evaluation to the European Chemicals Agency (‘the Agency’).

(4) On 25 March 2019, the Agency submitted to the Commission an opinion(2), including the proposed terms and conditions of the authorisation, the draft summary of the biocidal product characteristics (‘SPC’) of ‘Contec IPA Product Family’ and the final assessment report on the biocidal product family in accordance with Article 44(3) of Regulation (EU) No 528/2012.

(5) The opinion concludes that ‘Contec IPA Product Family’ is a ‘biocidal product family’ within the meaning of Article 3(1)(s) of Regulation (EU) No 528/2012, that it is eligible for Union authorisation in accordance with Article 42(1) of that Regulation and that subject to compliance with the proposed terms and conditions and the draft SPC, it meets the conditions laid down in Article 19(1) and (6) of that Regulation.

(6) On 28 May 2019, the Agency transmitted to the Commission the draft SPC in all the official languages of the Union in accordance with Article 44(4) of Regulation (EU) No 528/2012.

(7) The Commission concurs with the opinion of the Agency and considers it therefore appropriate to grant a Union authorisation for ‘Contec IPA Product Family’.

(8) In the opinion the Agency also recommends that a long-term storage test at ambient temperature for wipes in their commercial packaging be conducted by the authorisation holder as a condition in the authorisation. The Commission agrees with that recommendation and considers that the submission of this test should be a condition relating to the making available on the market and use of the biocidal product family pursuant to Article 22(1) of Regulation (EU) No 528/2012. The Commission also considers that the fact that data is to be provided after the authorisation is granted does not affect the conclusion on the fulfilment of the condition under Article 19(1)(d) of that Regulation on the basis of the existing data.

(9) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,

HAS ADOPTED THIS REGULATION:

Article 1U.K.

A Union authorisation with authorisation number EU-0020460-0000 is granted to Contec Europe for the making available on the market and use of the biocidal product family ‘Contec IPA Product Family’, subject to compliance with the terms and conditions set out in Annex I and in accordance with the summary of the biocidal product characteristics set out in Annex II.

The Union authorisation is valid from 26 December 2019 until 30 November 2029.

Article 2U.K.

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 29 November 2019.

For the Commission

The President

Jean-Claude Juncker

ANNEX IU.K. TERMS AND CONDITIONS (EU-0020460-0000)

The authorisation holder shall conduct a long-term storage test at ambient temperature for wipes in their commercial packaging.

By 31 July 2021 the authorisation holder shall submit the results of the test to the Agency.

ANNEX IIU.K. Summary of product characteristics for a biocidal product family

Contec IPA Product Family

Product type 2 — Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants)

Product type 4 — Food and feed area (Disinfectants)

Authorisation number: EU-0020460-0000

R4BP asset number: EU-0020460-0000

PART IU.K. FIRST INFORMATION LEVEL

1.ADMINISTRATIVE INFORMATIONU.K.

1.1. Family name U.K.

NameContec IPA Product Family

1.2. Product type(s) U.K.

Product type(s)

PT02 — Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants)

PT04 — Food and feed area (Disinfectants)

1.3. Authorisation holder U.K.

Name and address of the authorisation holderNameContec Europe
AddressZl Du Prat, Avenue Paul Duplaix, 56000, Vannes, France
Authorisation numberEU-0020460-0000
R4BP asset numberEU-0020460-0000
Date of the authorisation26 December 2019
Expiry date of the authorisation30 November 2029

1.4. Manufacturer(s) of the biocidal products U.K.

Name of manufacturerContec Inc.
Address of manufacturer525 Locust Grove, SC 29303 Spartanburg United States
Location of manufacturing sites525 Locust Grove, SC 29303 Spartanburg United States
Name of manufacturerContec Cleanroom Technology (Suzhou) Co., Ltd. China
Address of manufacturer17 Longyun Road, Suzhou Industrial Park, 215024 Suzhou China
Location of manufacturing sites17 Longyun Road, Suzhou Industrial Park, 215024 Suzhou China
Name of manufacturerContec Cleanroom (UK) Ltd
Address of manufacturerUnit 6A, Wansbeck Business Park, Rotary Parkway, NE63 8QW Ashington, Northumberland United Kingdom
Location of manufacturing sitesUnit 6A, Wansbeck Business Park, Rotary Parkway, NE63 8QW Ashington, Northumberland United Kingdom
Name of manufacturerFlexible Medical Packaging
Address of manufacturerUnit 8 Hightown, White Cross Industrial Estate, LA1 4XS Lancaster, Lancashire United Kingdom
Location of manufacturing sitesUnit 8 Hightown, White Cross Industrial Estate, LA1 4XS Lancaster, Lancashire United Kingdom

1.5. Manufacturer(s) of the active substance(s) U.K.

Active substancePropan-2-ol
Name of manufacturerBrenntag GmbH
Address of manufacturerMesseallee 11, 45131 Essen, Germany
Location of manufacturing sitesHaven 3222, Vondelingenweg 601, 3196 KK Vondelingenplaat Netherlands

2.PRODUCT FAMILY COMPOSITION AND FORMULATIONU.K.

2.1. Qualitative and quantitative information on the composition of the family U.K.

Common nameIUPAC nameFunctionCAS numberEC numberContent (%)
MinMax
Propan-2-olActive Substance67-63-0200-661-762,962,9

2.2. Type(s) of formulation U.K.

Formulation(s)

AL (any other liquid) - RTU solution/trigger spray

AL (any other liquid) – RTU wipe

PART IIU.K. SECOND INFORMATION LEVEL — META SPC(S)

META SPC 1 U.K.

1.META SPC 1 ADMINISTRATIVE INFORMATIONU.K.

1.1. Meta SPC 1 identifier U.K.
IdentifierContec IPA Liquid Products
1.2. Suffix to the authorisation number U.K.
Number1-1
1.3. Product type(s) U.K.
Product type(s)

PT02 — Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants)

PT04 — Food and feed area (Disinfectants)

2.META SPC 1 COMPOSITIONU.K.

2.1. Qualitative and quantitative information on the composition of the meta SPC 1 U.K.
Common nameIUPAC nameFunctionCAS numberEC numberContent (%)
MinMax
Propan-2-olActive Substance67-63-0200-661-762,962,9
2.2. Type(s) of formulation of the meta SPC 1 U.K.
Formulation(s)AL (any other liquid) - RTU solution/trigger spray

3.HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 1U.K.

Hazard statements

Highly flammable liquid and vapour.

Causes serious eye irritation.

May cause drowsiness or dizziness.

Repeated exposure may cause skin dryness or cracking.

Precautionary statements

If medical advice is needed, have product container or label at hand.

Keep out of reach of children.

Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.

Keep container tightly closed.

Avoid breathing vapours.

Wash hands thoroughly after handling.

Use only outdoors or in a well-ventilated area.

Wear eye protection.

IF ON SKIN (or hair):Take off immediately all contaminated clothing. Rinse skin with water.

IF INHALED: Remove person to fresh air and keep comfortable for breathing.

IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

Call a Poison centre if you feel unwell.

If eye irritation persists: Get medical advice.

In case of fire: Use alcohol resistant foam to extinguish.

Store in a well-ventilated place. Keep cool.

Store locked up.

Dispose of contents/container in accordance with local regulations.

4.AUTHORISED USE(S) OF THE META SPC 1U.K.

4.1. Use description U.K.
Table 1

Use # 1 – Professional use

Product type

PT02 — Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants)

PT04 — Food and feed area (Disinfectants)

Where relevant, an exact description of the authorised use
Target organism(s) (including development stage)

Bacteria

Mycobacteria

Yeasts

Field(s) of use

Indoor

Disinfectant for use against bacteria, mycobacteria and yeast on hard, non-porous surfaces in cleanrooms for biotechnology, pharmaceutical, manufacture of medical devices, healthcare industries and other critical life science applications, and in industrial food and feed preparation areas.

Acceptable use temperature: room temperature (20±2 °C)

Application method(s)

Spraying and wiping

Application rate(s) and frequency

50 ml product per m2 of surface.

Wiping: 1 minute contact time for bacteria and myobacteria

3 minutes contact time for yeast

Category(ies) of usersProfessional
Pack sizes and packaging material

High-density polyethylene (HDPE) trigger spray bottle -0,5 L – 1 L

HDPE capped refill bottle – 5 L

4.1.1. Use-specific instructions for use U.K.

See general directions for use

4.1.2. Use-specific risk mitigation measures U.K.

See general directions for use

4.1.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment U.K.

See general directions for use

4.1.4. Where specific to the use, the instructions for safe disposal of the product and its packaging U.K.

See general directions for use

4.1.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage U.K.

See general directions for use

5.GENERAL DIRECTIONS FOR USE(3) OF THE META SPC 1U.K.

5.1. Instructions for use U.K.

Use at room temperature. For visibly soiled surfaces, cleaning prior to disinfection is required.

Wiping: Apply/Spray product to a suitable quality cleanroom wipe. Ensure the wipe is sufficiently and uniformly saturated before wiping the surface to be disinfected.

Ensure the surface is uniformly covered with the product then wipe to dry with a sterile cleanroom wipe.

Contact times: Wiping 1 minute for bacteria and mycobacteria 3 minutes for yeast.

Used wipes must be disposed of in a closed container.

5.2. Risk mitigation measures U.K.

Wash hands and exposed skin before meals and after use.

Avoid contact with eyes

‘For use in cleanrooms, adequate technical/engineering controls to remove airborne residues is mandatory e.g. room ventilation or LEV’

5.3. Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment U.K.

Likely direct or indirect adverse effects:

Headache, vertigo, hallucinations, respiratory depression, CNS depression or coma.

Severe irritation of the eyes and or ocular damage.

Nausea, vomiting, diarrhoea and haemorrhagic gastritis.

Pulmonary aspiration hazard may induce pneumonitis, hypotension and hypoglycemia.

First aid measures:

Relocate the individual from the exposure source and remove any contaminated/spattered clothing articles.

Eye contact: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention

Skin contact; wash affected area with plenty of water and soap. No scrubbing.

In case of ingestion: Do NOT induce vomiting and never give anything by mouth to an impaired or unconscious individual; if the individual is unconscious place individual in left sideways (recovery) position with the head lowered and the knees bent.

Keep the individual calm and at rest, conserve body temperature and control breathing. If necessary check for pulse and initiate artificial respiration.

Take the individual to a healthcare centre and bring packaging or label whenever possible.

NEVER LEAVE THE AFFECTED INDIVIDUAL UNATTENDED!

Advice for medical and healthcare personnel:

Monitor vital signs and provide symptomatic and supportive treatment.

Evaluate endoscopic procedure in case of ingestion.

Monitor glycaemia and ketones.

Ipecac use is contraindicated.

WHEN ASKING FOR MEDICAL ADVICE KEEP PACKAGING OR LABEL AT HAND AND CALL YOUR LOCAL POISON CONTROL CENTRE [INSERT LOCAL NUMBER HERE].

5.4. Instructions for safe disposal of the product and its packaging U.K.

Dispose of contents/container in accordance with local regulations.

Do not re-use empty container for any other purpose.

5.5. Conditions of storage and shelf-life of the product under normal conditions of storage U.K.

Store in a cool, dry, well-ventilated place in original container.

Keep away from sources of ignition.

Keep away from direct sunlight.

Keep container tightly closed.

Shelf-life: 2 years

6.OTHER INFORMATIONU.K.

The product contains propan-2-ol (CAS No: 67-63-0), for which an European reference value of 129,28 mg/m3 for the professional user was agreed and used for the risk assessment of the product.

7.THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 1U.K.

7.1. Trade name(s), authorisation number and specific composition of each individual product U.K.
Trade name(s)

Contec 70 % IPA FBC570I

Contec Sterile 70 % IPA SBT170IW

Contec Sterile 70 % IPA SBT0570IW

Contec 70 % IPA FBT170I

Authorisation numberEU-0020460-0001 1-1
Common nameIUPAC nameFunctionCAS numberEC numberContent (%)
Propan-2-olActive Substance67-63-0200-661-762,9

META SPC 2 U.K.

1.META SPC 2 ADMINISTRATIVE INFORMATIONU.K.

1.1. Meta SPC 2 identifier U.K.
IdentifierContec IPA Wipes
1.2. Suffix to the authorisation number U.K.
Number1-2
1.3. Product type(s) U.K.
Product type(s)

PT02 — Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants)

PT04 — Food and feed area (Disinfectants)

2.META SPC 2 COMPOSITIONU.K.

2.1. Qualitative and quantitative information on the composition of the meta SPC 2 U.K.
Common nameIUPAC nameFunctionCAS numberEC numberContent (%)
MinMax
Propan-2-olActive Substance67-63-0200-661-762,962,9
2.2. Type(s) of formulation of the meta SPC 2 U.K.
Formulation(s)AL (any other liquid) – RTU wipe

3.HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 2U.K.

Hazard statements

Highly flammable liquid and vapour.

Causes serious eye irritation.

May cause drowsiness or dizziness.

Repeated exposure may cause skin dryness or cracking.

Precautionary statements

If medical advice is needed, have product container or label at hand.

Keep out of reach of children.

Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.

Keep container tightly closed.

Avoid breathing vapours.

Wash hands thoroughly after handling.

Use only outdoors or in a well-ventilated area.

Wear eye protection.

IF ON SKIN (or hair):Take off immediately all contaminated clothing. Rinse skin with water.

IF INHALED: Remove person to fresh air and keep comfortable for breathing.

IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

Call a POISON CENTRE if you feel unwell.

If eye irritation persists: Get medical advice.

In case of fire: Use alcohol resistant foam to extinguish.

Store in a well-ventilated place. Keep cool.

Store locked up.

Dispose of contents/container in accordance with local regulations.

4.AUTHORISED USE(S) OF THE META SPC 2U.K.

4.1. Use description U.K.
Table 2

Use # 1 – Professional use

Product type

PT02 — Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants)

PT04 — Food and feed area (Disinfectants)

Where relevant, an exact description of the authorised use-
Target organism(s) (including development stage)

Bacteria

Mycobacteria

Yeasts

Field(s) of use

Indoor

Disinfectant for use against bacteria, mycobacteria and yeast on hard, non-porous surfaces in cleanrooms for biotechnology, pharmaceutical, manufacture of medical devices, healthcare industries and other critical life science applications, and in industrial food and feed preparation areas.

Acceptable use temperature: room temperature (20±2 °C)

Application method(s)

Wiping

Application rate(s) and frequency

1 minute contact time for bacteria and mycobacteria

3 minutes contact time for yeast

Category(ies) of usersProfessional
Pack sizes and packaging material

Impregnated 100 % polypropylene wipes in:

  • HDPE canister with HDPE cap – 150 wipes (1,7 L or 2,15 L)

  • Polyethylene terephthalate (PET)/polyethylene (PE) packet sealed with PET/PE flow wrap – 30, 40 or 50 wipes

Impregnated 100 % polyester wipes in:

  • HDPE canister with HDPE cap – 100 wipes (2,25 L)

  • PET/PE packet sealed with PET/PE flow wrap – 20 wipes

Impregnated 100 % knitted polyester wipes in:

  • PET/PE packet sealed with PET/PE flow wrap – 8, 10, 20, 30 or 50 wipes

Impregnated 55 % cellulose/45 % polyester wipes in:

  • HDPE canister with HDPE cap – 100 wipes (2,25 L)

  • PET/PE packet sealed with PET/PE flow wrap – 24, 30, 50 or 75 wipes

Impregnated 50 % rayon/50 % polyester wipes in:

  • HDPE canister with HDPE cap - 700 wipes (11,4 L)

4.1.1. Use-specific instructions for use U.K.

See general directions for use

4.1.2. Use-specific risk mitigation measures U.K.

See general directions for use

4.1.3. Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment U.K.

See general directions for use

4.1.4. Where specific to the use, the instructions for safe disposal of the product and its packaging U.K.

See general directions for use

4.1.5. Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage U.K.

See general directions for use

5.GENERAL DIRECTIONS FOR USE(4) OF THE META SPC 2U.K.

5.1. Instructions for use U.K.

For soiled surfaces, cleaning prior to disinfection is required.

Ensure the surface is uniformly covered with the product, allow to act for a contact time of 1 minute for bactericidal and mycobactericidal action and 3 minutes for yeasticidal action

5.2. Risk mitigation measures U.K.

Wash hands and exposed skin before meals and after use.

Avoid contact with eyes

‘For use in cleanrooms, adequate technical/engineering controls to remove airborne residues is mandatory e.g. room ventilation or LEV’

5.3. Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment U.K.

Likely direct or indirect adverse effects:

Headache, vertigo, hallucinations, respiratory depression, CNS depression or coma.

Severe irritation of the eyes and or ocular damage.

Nausea, vomiting, diarrhoea and haemorrhagic gastritis.

Pulmonary aspiration hazard may induce pneumonitis, hypotension and hypoglycemia.

First aid measures:

Relocate the individual from the exposure source and remove any contaminated/spattered clothing articles.

Eye contact: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention

Skin contact; wash affected area with plenty of water and soap, No scrubbing.

In case of ingestion; Do NOT induce vomiting and never give anything by mouth to an impaired or unconscious individual; if the individual is unconscious place individual in left sideways (recovery) position with the head lowered and the knees bent.

Keep the individual calm and at rest, conserve body temperature and control breathing. If necessary check for pulse and initiate artificial respiration.

Take the individual to a healthcare centre and bring packaging or label whenever possible.

NEVER LEAVE THE AFFECTED INDIVIDUAL UNATTENDED!

Advice for medical and healthcare personnel:

Monitor vital signs and provide symptomatic and supportive treatment.

Evaluate endoscopic procedure in case of ingestion.

Monitor glycaemia and ketones.

Ipecac use is contraindicated.

WHEN ASKING FOR MEDICAL ADVICE KEEP PACKAGING OR LABEL AT HAND AND CALL YOUR LOCAL POISON CONTROL CENTRE [INSERT LOCAL NUMBER HERE].

5.4. Instructions for safe disposal of the product and its packaging U.K.

Dispose of contents/container in accordance with local regulations.

Do not re-use empty container for any other purpose.

Used wipes must be disposed in a closed container

Dispose of used wipes by dry waste to landfill

5.5. Conditions of storage and shelf-life of the product under normal conditions of storage U.K.

Store in a cool, dry, well-ventilated place in original container.

Keep away from sources of ignition.

Keep away from direct sunlight.

Keep container tightly closed.

Shelf-life: 2 years

6.OTHER INFORMATIONU.K.

Polypropylene, polyester, kitted polyester, 55 % cellulose/45 % polyester or 50 % rayon/50 % polyester wipes, 34-240 gsm, containing 5 - 38 ml product (2,75 – 20,9 g propan-2-ol)

The product contains propan-2-ol (CAS No: 67-63-0), for which an European reference value of 129,28 mg/m3 for the professional user was agreed and used for the risk assessment of the product.

7.THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 2U.K.

7.1. Trade name(s), authorisation number and specific composition of each individual product U.K.
Trade name(s)

PROSAT MBPP PS-840IR

PROSAT MBPP PS-911

PROSAT MBPP PS-911EB

PROSAT MBPP PS-LPP-7030

PROSAT MBPP PS-LPP-7030IR

PROSAT MBPP PSPP0039

PROSAT MBPP PSPP0043

SATWipes MBPP SWPP0003

PROSAT Delta PS-7030IR

SATWipes nonwoven polyester SAT-C3-7030

Spec-Wipe 4 115-0039

PROSAT Polynit Heatseal PS-HS9-7030

PROSAT EasyReach PSME0001

PROSAT Polynit Heatseal PSPS0047

PROSAT Polynit Heatseal PSPS0076

PROSAT Polynit Heatseal PSPS0091

PROSAT Polynit Heatseal PSWE0001

PROSAT Polynit Heatseal PSWE0002

PROSAT Polynit Heatseal PSWE0003

Spec-Wipe 3 115-0034

PROSAT Sigma PSC20001

PROSAT Sigma PSC20002

PROSAT Theta PSC20005

PROSAT Theta PSC20006

PROSAT Theta PSC20009

PROSAT Theta PSC20010

PROSAT Theta PSCP0001

PROSAT Theta PSCS1010

PROSAT Theta PSCS1010IR

SATWipes polyester/cellulose SAT-C1-7030

SATWipes presaturated wipes SWNW0013

Authorisation numberEU-0020460-0002 1-2
Common nameIUPAC nameFunctionCAS numberEC numberContent (%)
Propan-2-olActive Substance67-63-0200-661-762,9
(2)

ECHA opinion of 28 February 2019 on the Union authorisation of ‘Contec IPA Product Family’ (ECHA/BPC/221/2019).

(3)

Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses within the meta SPC 1.

(4)

Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses within the meta SPC 2.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources